BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 23207610)

  • 1. Diabetes and pancreatic cancer.
    Muniraj T; Chari ST
    Minerva Gastroenterol Dietol; 2012 Dec; 58(4):331-45. PubMed ID: 23207610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diabetes and cancer risk: oncologic considerations].
    Rosta A
    Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes and cancer: placing the association in perspective.
    Andersen DK
    Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):81-6. PubMed ID: 23422245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes and pancreatic cancer.
    Li D
    Mol Carcinog; 2012 Jan; 51(1):64-74. PubMed ID: 22162232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes and pancreatic cancer: chicken or egg?
    Magruder JT; Elahi D; Andersen DK
    Pancreas; 2011 Apr; 40(3):339-51. PubMed ID: 21412116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ORIGIN trial shows safety and efficacy of insulin glargine: no adverse cardiovascular outcomes after a 6.2-year follow up of early insulin use.
    Lombard L; Distiller L; Aalbers J
    Cardiovasc J Afr; 2012 Jul; 23(6):357-8. PubMed ID: 23091824
    [No Abstract]   [Full Text] [Related]  

  • 8. Higher Waist Circumference, Fasting Hyperinsulinemia And Insulin Resistance Characterize Hypertensive Patients With Impaired Glucose Metabolism.
    De Pergola G; Nardecchia A; Cirillo M; Boninfante B; Sciaraffia M; Giagulli VA; Triggiani V; Silvestris F
    Endocr Metab Immune Disord Drug Targets; 2015; 15(4):297-301. PubMed ID: 25944063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes and pancreatic cancer.
    Chaudhry ZW; Hall E; Kalyani RR; Cosgrove DP; Yeh HC
    Curr Probl Cancer; 2013; 37(5):287-92. PubMed ID: 24331184
    [No Abstract]   [Full Text] [Related]  

  • 10. Pancreatic cancer and diabetes: A two-way relationship in the perspective of diabetologist.
    Salvatore T; Marfella R; Rizzo MR; Sasso FC
    Int J Surg; 2015 Sep; 21 Suppl 1():S72-7. PubMed ID: 26123386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus and the risk of cancer.
    Pandey A; Forte V; Abdallah M; Alickaj A; Mahmud S; Asad S; McFarlane SI
    Minerva Endocrinol; 2011 Sep; 36(3):187-209. PubMed ID: 22019750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal insulin and cardiovascular and other outcomes in dysglycemia.
    ; Gerstein HC; Bosch J; Dagenais GR; Díaz R; Jung H; Maggioni AP; Pogue J; Probstfield J; Ramachandran A; Riddle MC; Rydén LE; Yusuf S
    N Engl J Med; 2012 Jul; 367(4):319-28. PubMed ID: 22686416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and pancreatic cancer.
    Cui Y; Andersen DK
    Endocr Relat Cancer; 2012 Oct; 19(5):F9-F26. PubMed ID: 22843556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and early signs of pancreatic cancer in diabetes: screening strategy based on diabetes onset age.
    Mizuno S; Nakai Y; Isayama H; Yanai A; Takahara N; Miyabayashi K; Yamamoto K; Kawakubo K; Mohri D; Kogure H; Sasaki T; Yamamoto N; Sasahira N; Hirano K; Tsujino T; Ijichi H; Tateishi K; Akanuma M; Tada M; Koike K
    J Gastroenterol; 2013 Feb; 48(2):238-46. PubMed ID: 22735942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic cancer and glucose metabolism.
    Saruç M; Karaarslan M; Rasa K; Saygili O; Ince U; Baysal C; Pour PM; Cakmakçi M; Tözün N
    Turk J Gastroenterol; 2009 Dec; 20(4):257-60. PubMed ID: 20084568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium.
    Bosetti C; Rosato V; Li D; Silverman D; Petersen GM; Bracci PM; Neale RE; Muscat J; Anderson K; Gallinger S; Olson SH; Miller AB; Bas Bueno-de-Mesquita H; Scelo G; Janout V; Holcatova I; Lagiou P; Serraino D; Lucenteforte E; Fabianova E; Baghurst PA; Zatonski W; Foretova L; Fontham E; Bamlet WR; Holly EA; Negri E; Hassan M; Prizment A; Cotterchio M; Cleary S; Kurtz RC; Maisonneuve P; Trichopoulos D; Polesel J; Duell EJ; Boffetta P; La Vecchia C; Ghadirian P
    Ann Oncol; 2014 Oct; 25(10):2065-2072. PubMed ID: 25057164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus: a risk factor for pancreatic cancer?
    Yalniz M; Pour PM
    Langenbecks Arch Surg; 2005 Feb; 390(1):66-72. PubMed ID: 15083362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type II diabetes mellitus and impaired glucose regulation in Caucasian children and adolescents with obesity living in Germany.
    Wabitsch M; Hauner H; Hertrampf M; Muche R; Hay B; Mayer H; Kratzer W; Debatin KM; Heinze E
    Int J Obes Relat Metab Disord; 2004 Feb; 28(2):307-13. PubMed ID: 14724655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes and cancer: Could vitamin D provide the link?
    Ahmad S; Chowdhury TA; Boucher BJ
    J Diabetes Complications; 2013; 27(2):184-90. PubMed ID: 23164631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin and pancreatic cancer: Is there a role?
    De Souza A; Khawaja KI; Masud F; Saif MW
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):235-42. PubMed ID: 26740120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.